COugh Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop previoUs ACE-i Treatment Due to couGH in Slovakia
Information source: Bayer
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Hypertension
Intervention: Telmisartan (Kinzal/Pritor, BAY68-9291) (Drug)
Phase: N/A
Status: Completed
Sponsored by: Bayer Official(s) and/or principal investigator(s):
Bayer Study Director, Study Director, Affiliation: Bayer
Summary
In the light of ONTARGET and TRANSCEND studies results, it would be interesting to
investigate the real-life telmisartan treatment tolerability. It is well known and accepted
that the Real-life setting is much more adequate to reflect the antihypertensive and safety
properties of the drug in comparison to the organized and scheduled setting of the clinical
trial. Because there are not much data on the cough in relation to telmisartan, therefore it
would we worth to observe the cough frequency and general treatment tolerance in patients
treated with telmisartan, who had to stop their previous ACE-I treatment due to cough.
Clinical Details
Official title: Cough Among Hypertensive Patients Treated With Telmisartan, Who Had to Stop Previous ACE-i Treatment Due to Cough
Study design: Observational Model: Cohort, Time Perspective: Prospective
Primary outcome: Cough frequency among telmisartan treated patients, who had to stop their previous ACE-I treatment due to cough
Secondary outcome: Number of Participants with Adverse Events among patients, who had to stop their previous ACE-I treatment due to cough
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Hypertension
- Age > 18
- ACE-I related cough
Exclusion Criteria:
- Current treatment with telmisartan
- Cholestatic disorders and severe hepatic failure
- Allergy to telmisartan
- Pregnancy and lactation period
Locations and Contacts
Many Locations, Slovakia
Additional Information
Click here and search for drug information provided by the FDA. Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.
Starting date: January 2010
Last updated: November 14, 2012
|
